Belumosudil
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Rezurock is the brand name for belumosudil, an oral prescription tablet manufactured by Kadmon Pharmaceuticals, LLC. Each tablet contains 200 mg of belumosudil and was approved under NDA214783, with marketing starting in July 2021. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Belumosudil
Access the FDA dataset for Belumosudil — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025